Asia-Pacific Respiratory Care Devices Market Outlook, 2028

The Asia-Pacific respiratory care devices market is expanding rapidly, owing to a mix of reasons such as rising respiratory disorders, aging populations, increased respiratory health awareness, and technological improvements in healthcare. In the Asia-Pacific area, respiratory problems such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea are on the rise. Air pollution, smoking, and changing lifestyles have all contributed to the rising prevalence of these diseases. As a result, there is an increasing demand for respiratory care devices that help with disease management and treatment. The Asia-Pacific region has a rapidly aging population. Because age is a significant risk factor for respiratory disorders, the region's demographic transition has increased the need for respiratory care devices. As people age, they are more susceptible to conditions like COPD and require respiratory devices to maintain their quality of life. The Asia-Pacific region is becoming increasingly conscious of the importance of respiratory health and the early detection of respiratory disorders. Public health campaigns, healthcare initiatives, and educational programs are all helping to increase awareness of respiratory diseases. This increased awareness is prompting earlier interventions and an increase in the usage of respiratory care devices. The Asia-Pacific respiratory care device market is benefiting from ongoing medical technology improvements. Innovative products that are more user-friendly, portable, and efficient are being developed by manufacturers. Among the cutting-edge technologies making respiratory care more accessible and convenient for patients in the region are smart inhalers, portable oxygen concentrators, and telehealth options. Emerging economies such as China and India are witnessing substantial growth in healthcare infrastructure and investments. These countries are becoming significant players in the respiratory care devices market, both as manufacturers and consumers. According to the research report, “Asia-Pacific Respiratory Care Devices Market Outlook, 2028” published by Bonafide Research, the market is expected to grow with more than 10% CAGR from 2023 to 2028. The Asia-Pacific region comprises a vast range of temperatures and altitudes, from the arid deserts of the Middle East to the mountainous regions of the Himalayas. Respiratory care devices in this region are specifically developed to perform efficiently in these diverse settings. They are designed to resist high temperatures, ensuring that patients receive constant and dependable therapy regardless of their geographic location. Asia-Pacific is home to a diverse range of languages and dialects. To accommodate a diverse population, respiratory care devices frequently have bilingual interfaces. This enables healthcare workers to communicate with patients in their local languages, fostering improved understanding and patient compliance. Traditional medical systems such as Ayurveda, Traditional Chinese medicine, and Unani are commonly practiced alongside Western medicine in many countries in the Asia-Pacific. Respiratory care devices in the region are meant to work in tandem with these traditional procedures, resulting in a more comprehensive and patient-centered approach to respiratory health. The Asia-Pacific region is well-known for its air pollution problems, particularly in densely populated urban areas. Advanced filtering systems are built into respiratory care devices to help patients cope with the negative consequences of air pollution. Devices also feature real-time air quality monitoring to help healthcare providers make informed treatment decisions. The Asia-Pacific region has a high birth rate and therefore has a huge population of children and newborns. In this region, respiratory care devices are frequently designed for pediatric and newborn care, with smaller sizes, gentle breathing modes, and improved monitoring capabilities tailored to the specific needs of young patients. Asia-Pacific countries are not only users of respiratory care devices but also important players in the development of cutting-edge technologies. Regional R&D efforts frequently result in the development of cutting-edge equipment and therapies that benefit both local and global populations.

Based on the report market is divided in five major countries China, Japan, India, Australia and South Korea. Among them India is expected to grow at fastest rate in Asia-Pacific region. India has one of the world's largest populations, and it is characterized by an increasing geriatric population. The frequency of respiratory disorders rises with age. As a result, demand for respiratory care devices is driven by the sheer size of the Indian population. The Indian government has initiated a number of healthcare initiatives aimed at increasing access to medical services and the availability of medical equipment. Ayushman Bharat and other schemes aim to provide financial protection for patients while also encouraging investment in healthcare infrastructure, such as respiratory care facilities and technologies. In India, there is a growing awareness of respiratory health issues, thanks in part to educational campaigns and the work of healthcare organizations. As more people become aware of the significance of respiratory health, there is a greater willingness to seek diagnosis and treatment, further boosting demand for respiratory care devices. India has emerged as a medical tourism hotspot, luring patients from all over the world in search of low-cost, high-quality healthcare. This surge of international patients increases demand for modern respiratory care devices in India's healthcare institutions. Increased investment in the Indian healthcare sector has come from both domestic and international enterprises, supporting innovation in the development of respiratory care products. Local manufacturers are also developing low-cost devices, which is fueling growth. The growing middle class in India, as well as increased disposable earnings, are making respiratory treatment more affordable. This economic expansion makes it easier for innovative medical technologies to be adopted. In terms of product type market includes therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. Among them consumables and accessories type is predicted to grow at fastest in Asia-Pacific market.

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, are becoming more common in many Asian countries. Patients with chronic diseases require continual supplies of consumables such as inhaler spacers, nebulizer kits, and oxygen masks to adequately manage their conditions. Infection management and prevention have become increasingly important, particularly in healthcare settings. Disposable masks, filters, and breathing circuits are critical in lowering the danger of cross-contamination and maintaining good hygiene standards in respiratory treatment. Advances in respiratory care technology have resulted in the development of specialized consumables and accessories. These cutting-edge devices, including high-efficiency particulate air (HEPA) filters and improved humidification systems, are in high demand because they improve patient outcomes. The rise of the region's healthcare infrastructure, including hospitals and clinics, has resulted in a stronger demand for consumables and accessories to outfit these facilities. Respiratory care consumables are critical to the operation of these facilities. As Asia-Pacific countries become more popular as medical tourism destinations, there is a greater demand for consumables and accessories to assist overseas patient’s treatment. During their stay, these guests frequently require a variety of respiratory care products. Based on disease indication market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other disease indications. Furthermore based on end user market is divided into hospitals, ambulatory care centers (ACCs), home care settings and other end user. Asian countries experience severe air quality problems, including high levels of pollution and particle matter. Poor air quality can aggravate respiratory disorders such as asthma, rendering people more susceptible to episodes. As urbanization and industrialization grow, worries about air quality contribute to the rising prevalence of asthma. Changes in lifestyle, such as increased sedentary behavior and food habits, have contributed to an increase in obesity and other asthma risk factors. Obesity is a known risk factor for the development of asthma and can worsen the condition in those who already have it. Rapid urbanization has resulted in overcrowding, greater exposure to allergens inside, and increased automobile emissions, all of which can contribute to the development and worsening of asthma. The Asia-Pacific area is experiencing demographic shifts with an aging population. Chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma are more common in older people. Home care settings offer a more pleasant and cost-effective alternative to managing certain chronic illnesses in the elderly. Advances in respiratory care devices have enabled comprehensive care and monitoring to be provided in the home. Portable oxygen concentrators, non-invasive ventilators, and smart inhalers are just a few examples of technologies that help patients manage their respiratory illnesses at home. Home care is frequently less expensive than hospital treatment. They alleviate the financial strain on consumers and healthcare systems, making healthcare more accessible and affordable to a wider spectrum of people.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Companies Covered in this report: Koninklijke Philips N.V., Medtronic Inc, Masimo Corporation, Cardinal Health, Inc, Medline Industries, Baxter International Inc., Stryker Corporation, Siemens AG, GE HealthCare Technologies, Inc, Getinge AB, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited. Considered in this report: • Geography: Asia-Pacific • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028 Aspects covered in this report: • Asia-Pacific Respiratory Care Devices market Outlook with its value and forecast along with its segments • Country-wise Respiratory Care Devices market analysis • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation Country covered in the report: • China • Japan • India • Australia • South Korea By Product Type: • Therapeutic Devices • Monitoring Devices • Diagnostic Devices • Consumables and Accessories By Disease Indication: • Chronic Obstructive Pulmonary disease (COPD) • Sleep Apnea • Asthma • Infectious Diseases • Other Disease Indications By End User: • Hospitals • Ambulatory Care Centers (ACCs) • Home Care Settings • Other End User The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.